Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolter, F.
Right arrow Articles by Stein, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolter, F.
Right arrow Articles by Stein, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Colorectal Cancer
© 2002 The American Society for Nutritional Sciences J. Nutr. 132:298-302, 2002

Piceatannol, a Natural Analog of Resveratrol, Inhibits Progression through the S Phase of the Cell Cycle in Colorectal Cancer Cell Lines1

Freya Wolter, Antje Clausnitzer, Bora Akoglu and Jürgen Stein2

2nd Department of Medicine, J. W. Goethe University, 60590 Frankfurt/Main, Germany

2To whom correspondence should be addressed. E-mail: j.stein{at}em.uni-frankfurt.de.

Piceatannol, a naturally occurring analog of resveratrol, was previously identified as the active ingredient in herbal preparations in folk medicine and as an inhibitor of p72Syk. We studied the effects of piceatannol on growth, proliferation, differentiation and cell cycle distribution profile of the human colon carcinoma cell line Caco-2. Growth of Caco-2 and HCT-116 cells was analyzed by crystal violet assay, which demonstrated dose- and time-dependent decreases in cell numbers. Treatment of Caco-2 cells with piceatannol reduced proliferation rate. No effect on differentiation was observed. Determination of cell cycle distribution by flow cytometry revealed an accumulation of cells in the S phase. Immunoblotting demonstrated that cyclin-dependent kinases (cdk) 2 and 6, as well as cdc2 were expressed at steady-state levels, whereas cyclin D1, cyclin B1 and cdk 4 were downregulated. The abundance of p27Kip1 was also reduced, whereas the protein level of cyclin E was enhanced. Cyclin A levels were enhanced only at concentrations up to 100 µmol/L. These changes also were observed in studies with HCT-116 cells. On the basis of our findings, piceatannol can be considered to be a promising chemopreventive or anticancer agent.


KEY WORDS: • piceatannol • Caco-2 cells • cell cycle • colon cancer




This article has been cited by other articles:


Home page
In VivoHome page
K. DIMAS, S. HATZIANTONIOU, J. H. WYCHE, and P. PANTAZIS
A Mastic Gum Extract Induces Suppression of Growth of Human Colorectal Tumor Xenografts in Immunodeficient Mice
In Vivo, January 1, 2009; 23(1): 63 - 68.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Ulrich, S. M. Loitsch, O. Rau, A. von Knethen, B. Brune, M. Schubert-Zsilavecz, and J. M. Stein
Peroxisome Proliferator-Activated Receptor {gamma} as a Molecular Target of Resveratrol-Induced Modulation of Polyamine Metabolism.
Cancer Res., July 15, 2006; 66(14): 7348 - 7354.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
Y.-J. Chun, S.-K. Lee, and M. Y. Kim
MODULATION OF HUMAN CYTOCHROME P450 1B1 EXPRESSION BY 2,4,3',5'-TETRAMETHOXYSTILBENE
Drug Metab. Dispos., December 1, 2005; 33(12): 1771 - 1776.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M Maggiolini, A G Recchia, D Bonofiglio, S Catalano, A Vivacqua, A Carpino, V Rago, R Rossi, and S Ando
The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor {alpha} in human breast cancer cells
J. Mol. Endocrinol., October 1, 2005; 35(2): 269 - 281.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Wolter, S. Ulrich, and J. Stein
Molecular Mechanisms of the Chemopreventive Effects of Resveratrol and Its Analogs in Colorectal Cancer: Key Role of Polyamines?
J. Nutr., December 1, 2004; 134(12): 3219 - 3222.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. C. Lazze, M. Savio, R. Pizzala, O. Cazzalini, P. Perucca, A. I. Scovassi, L. A. Stivala, and L. Bianchi
Anthocyanins induce cell cycle perturbations and apoptosis in different human cell lines
Carcinogenesis, August 1, 2004; 25(8): 1427 - 1433.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. Swanson-Mungerson, M. Ikeda, L. Lev, R. Longnecker, and T. Portis
Identification of latent membrane protein 2A (LMP2A) specific targets for treatment and eradication of Epstein-Barr virus (EBV)-associated diseases
J. Antimicrob. Chemother., August 1, 2003; 52(2): 152 - 154.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
F. Wolter, L. Turchanowa, and J. Stein
Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos
Carcinogenesis, March 1, 2003; 24(3): 469 - 474.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Wolter and J. Stein
Resveratrol Enhances the Differentiation Induced by Butyrate in Caco-2 Colon Cancer Cells
J. Nutr., July 1, 2002; 132(7): 2082 - 2086.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2002 by American Society for Nutrition